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Abstract 
Stem cells are neither differentiated nor specialized cells, which carry the potential to become any body tissue that one can think 
of. Differentiation of the cells occurs when a single fertilized egg follows the process of becoming a fully grown human. Stem 
cells can be stimulated under laboratory conditions to transform into specialized cells with specific functions, such as heart 
muscle cells, blood cells, or nerve cells when required. Researchers claim that it carries the potential to deliver beneficial 
treatments to a large portion of diseases where cells have been damaged. The ethical discussion relating to stem cells is closely 
linked with the way they can be obtained. The aim of this study is to evaluate stem cell research in ethical vision. 
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1. Introduction 
When the medical history is examined, it is evident that human beings have been in a desire to live a long life in a 
healthy manner and have always been in a constant effort to do so. Amongst these efforts, the thought of means for 
regaining the functions of a damaged organ as well as the organ regeneration has always been a topic of discussion. 
It is known that there is a constant formation of new cells to replace the old and dying ones in our body. The first 
and foremost foundation of all the cells in the living body is called “stem cell” which are cells capable of 
transforming into other cells with various roles. 
  
Stem cells have the remarkable potential to develop into many diverse cell types in the body during early life and 
growth. In addition, in many tissues they serve as a sort of internal repair system, dividing essentially without limit 
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to replenish other cells as long as the person or animal is still alive. Stem cells carry the characteristic properties of 
being plasticity, self-renewal and stems. 
 
Stem cells are neither differentiated nor specialized cells, which carry the potential to become any body tissue that 
one can think of. Differentiation of the cells occurs when a single fertilized egg follows the process of becoming a 
fully grown human. In this process, cells divide into becoming hundreds of other cell types with a specific job in the 
body. In return, they no longer can change their special status yet most lose their ability to divide again (Peter, 
2006). Having not lost this capacity, stem cells can be stimulated under laboratory conditions to transform into 
“specialized cells with specific functions, such as heart muscle cells, blood cells, or nerve cells” when required 
(Maienschein, Sunderland,  Rachel, Ankeny & Robert, 2008). Hence, researchers of stem cells claim that it carries 
the potential to deliver beneficial treatments to a large portion of diseases where cells have been lost or damaged, 
namely the Parkinson’s disease, Alzheimer’s, heart or muscle related injuries and so forth (Peter, 2006). 
 
1.1 The history of stem cell 
 
Since the 19th century, scientists from all over the world have studied stem cells, from plants, to mice, to patients in 
search of a cure for their diseases (Ramalho-Santos, Willenbring, 2007). 
 
In 1868 German biologist Ernst Haeckel uses the phrase stem cell to describe the fertilized egg that becomes an 
organism. William Sedgwick uses the term “stem cells” to describe the parts of a plant that grow and regenerate 
(Richardson, 1998). 
 
Leroy Stevens performing cancer research in mice, find the tumors, known as teratomas, contained mixtures of 
differentiated and undifferentiated cells, including hair, bone, intestinal and blood tissue in 1953 (Stevens, Little, 
1953). 
 
Ernest McCulloch and James Till perform experiments on the bone marrow of mice and observe that different blood 
cells come from a special class of cells. This is one of the first pieces of evidence of blood stem cells in 1963 
(McCulloch, Till, 2005). 
 
In 1981 Kaufman and Martin Evans at the University of Cambridge in England and Gail R. Martin in America were 
the first to derive embryonic stem cells (ES cells) from mouse embryos (Evans, Kaufman, 1981) (Martin, 1981). 
 
Dominique Bonnet and John Dick discover that leukemia comes from the same stem cells that make our blood cells 
in 1997 (Bonnet, Dick, 1997).  
 
A team at the University of Wisconsin, Madison, led by James Thomson and Jeffrey Jones, reports the creation of 
the first batch of human embryonic stem cells (1998), which they derived from early embryos (Thomson, Itskovitz-
Eldor  & Shapiro, 1998) . 
 
President George W. Bush signs an order authorizing the use of federal funds for research on a limited number of 
existing human embryonic stem cell lines in 2001 (The White House, Fact Sheet on Embryonic Stem Cell Research, 
2001). 
 
South Korean scientists have used therapeutic cloning to create 11 stem lines that match their donors, one year after 
reporting the creation of the first human stem cells with this method in 2005 (Hwang, Roh, Lee & et al, 2005). 
 
In 2007, three independent teams in Japan, Wisconsin and Boston, led by Shinya Yamanaka, James Thomson, and 
George Q. Daley, respectively, explained that they have created human Induced Pluripotent Stem (IPS) cells (Yu, 
Vodyanik, Smuga-Otto & et al, 2007). 
 
Geron Corporation announces the FDA’s approval for a limited phase I trial of Geron’s new treatment for spinal 
cord injuries. This was the first FDA approval of a clinical trial for a therapy based on human embryonic stem cells 
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in 2009 (Geron Corporation, 2009). 
 
President Barack Obama signs Executive Order 13505 to repeal some of the restrictions on human embryonic stem 
cell research funds placed by the previous administration in 2009. The order requires the “National Institutes of 
Health” to draft new guidelines for federal funding policies within 120 days (Executive order, 2009). 
 
1.2 Turkey and stem cell: research and legal status 
 
In Turkey, although legal arrangements were made within the recent years in order to ensure compliance with the 
rest of the world about stem cell research and application, there still exist ethical gaps albeit with problems arising 
out of the implementation of the legislation. 
 
 Our country is a party to the “Convention on Human Rights and Biomedicine - Oviedo Convention” and hence, 
embryonic stem cell research, including the research aimed at creating embryos, is prohibited in the “Assisted 
Reproductive Treatment Centers”. 
 
Ministry of Health (2005), with the purpose of providing an extensive coverage on matters that are in dispute has 
prepared and published towards the end of 2005 the “Assisted Reproductive Treatment Centers Regulation”. Under 
the regulation, embryonic stem cell research has been prohibited, although no prevention was brought to the 
research conducted on adult stem cells. This is due to the fact that adult stem cell treatment was being used in 
patients with leukemia at the time.  
 
On 04 May 2006, the Ministry has published the “Non-Embryonic Stem Cell Study Guide” for clinical purposes. 
According to this guide, non-embryonic stem cell research can only be conducted for clinical studies with the 
permission of "Stem Cell Transplantation Scientific Advisory Board”, established by the Ministry of Health, in 
scientific centers which have been approved by the Ministry. These centers, when applying to the scientific board to 
conduct stem cell research, need to prove that they possess the necessary ground knowledge, skills and equipment 
and should be able to provide the evidentiary data when needed (Rep. of Turkey Ministry of Health, 2006) (Türkiye 
Biyoetik Derneği, 2009).    
 
Published in 2009, “Stem Cell Coordination Center Working Principles and Guidelines” permitted the establishment 
of cord blood banks and organized the methods of hematopoietic stem cell treatments (Rep. of Turkey Ministry of 
Health, 2009). 
 
In 2013, the Ministry of Health and the Turkish Red Crescent commenced a study about patients waiting to be 
treated through stem cell transplantation. It was later decided that “Voluntary Donor Centers" were to be built by the 
Red Crescent to find donor candidates who are willing to donate either bone marrow or peripheral blood stem cells 
to “Bone Marrow Bank”, the institution established under the body of “Turkey Stem Cell Co-ordination Centre” 
(TÜRKOK, 2013), for patients in need of hematopoietic stem cell transplantation therapy. 
 
Despite these regulations with regards to stem cells in our country, legal gaps continue to exist. The Assisted 
Reproductive Treatment Centers Regulation has limited the penal sanction for the violation of any of its regulation 
articles to the extent in which the wrongdoing center’s activities are ceased by the Ministry of Health. On the other 
hand, the Turkish Penal Code, whilst not having an article on this topic, has not been subject to an amendment by       
a special law to impose a punishment for any violation of the Regulation’s provisions.  
2. The views about stem cell research    
One of the ethical and religious concerns relating to stem cells is closely linked with the way they can be obtained. 
Although stem cells can be acquired through various sources (including bone marrow or cord flow), it has been 
claimed by the scientists that much more promising stem cells must be harvested from the embryo itself (Cruzer, 
2010). A consequence of this is the fact that embryos cannot survive this procedure and a research in the prevention 
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of these losses from happening has so far been unsuccessful. Hence, how much value then an embryo must have has 
been on a subject of debate (Maienschein, Sunderland, Rachel, Ankeny & Robert, 2008). Secondly, a controversy 
exists in the field of cloning which is the technique that carries a potential to provide a “source of tailored” stem 
cells for the personalized medical treatments. The main question that is positioned in line with this is, through the 
extent of gene manipulation of human beings, whether the scientists are trying to “play God” and that in return, 
whether this may have serious risks to our society (Peter, 2006). Lastly, whether the allowance and the increase of 
stem cell research without proper regulation would lead to the increase of egg donation and the exploitation of 
women remains a concern to many. Nevertheless, these claims do not come without their opposing sides to them and 
the balance that must be placed in the ethical ambit of the stem cell research will be explained below.  
 
The initial point of our discussion starts with the fact that Human Stem Cells (hESC) are difficult to isolate and 
establish a culture. Nevertheless, scientists have been able to obtain these cells from stem cell lines taken from 
embryos up to 4 or 6 days old – which later cannot survive. These stem cell lines allow cells to be divided without 
being specializing into any type of adult cell (Maienschein, Sunderland, Rachel, Ankeny & Robert, 2008). Almost 
all of these aforementioned embryos are created originally to be a part of in-vitro fertilization (IVF) treatment in 
health clinics to aid patients who cannot have successful pregnancies (Hug, 2006). Despite this, not all of them get 
implanted and hence, surpluses of unused embryos occur. If legal circumstances permit, couples no longer in need 
of this treatment can later donate their stored embryos for research purposes (Maienschein, Sunderland, Rachel, 
Ankeny & Robert, 2008). Although it is not illegal to destroy these embryos, controversy amongst the philosophers 
and religious clerks exist, since it is not yet clear whether they carry a personhood – whether they are deemed to be 
human beings with a moral status or not. If so, beliefs as to when this personhood begins to differ. Unfortunately, 
there exists no arbitrary point or a significant dividing line in “the continuum of physical growth” between an 
embryo to that of a developed human being (Hug, 2006). What this means in short is that one cannot assess as to 
when exactly the personhood has begun to exist. Therefore, it might sound logical to state that individuals are 
deemed to have this moral status both at their embryonic stage as well as after their development stage (Rickard, 
2002).  Opponents to stem cell research claim that, since each of us have come to life as an embryo and that our 
lives are worthy of respect and value, so must our lives be in earlier stages. The personhood according to them starts 
right from the conception (Maienschein, Sunderland, Rachel, Ankeny & Robert, 2008). This view has been favored 
in a number of religious sects, including Roman Catholic and Conservative Protestant Churches. Under their view, 
an embryo carries the status of a human being and that any intervention on the embryo would be the violation of that 
right. Hinduism too rejects animal research as well as the destruction of embryos since injuring sentient beings is 
prohibited (Sullivan, 2004). 
 
Contrarily, Sandel (2004) rejects this argument and supports his view by challenging it with an analogy. In this, he 
points out that although every oak tree was an acorn, it cannot make sense to conclude that every acorn is an oak 
tree. Hence, the loss of an acorn cannot be seen as the loss of a fully grown oak tree. Thus the mere fact that 
embryos can have the potential to become a developed human being does not make them one by default. In fact, as 
pointed out in previous paragraph, the research take place on embryos which are less than 6 days old and that at this 
stage of development, they would not be able to have a moral status. They do not have psychological, physical, 
intellectual or emotional characteristics as one would be able to associate with personhood (Rickard, 2002).  
Embryos can also be split to form twins up until the 14th day after fertilization. Further, a scientist can divide a five 
cell embryo into five embryos or can contrarily fuse them into one. After the 14th day, however, twining becomes no 
longer possible and that the life of one recognizable individual begins to exist (Knoepffler, 2004). The nervous 
system also begins to form at this period and this might play a role in finding the point in where the life of the 
embryo becomes solid (Hug, 2006). For these reasons, it can be argued that an embryo used for research purposes at 
its earliest stage (4-6 days old), since the cells they cannot deem to be individualized enough to have a moral weight 
of personhood, to be ethical. This view has been favored in a number of religions being; Islam, Judaism, Buddhism 
and the less conservative Protestant Churches. In Judaism, as long as the embryo is less than 40 days old, research 
on stem cells can be allowed. This is further illustrated with a view that the God has given us the power to create 
new technologies and that with the goal of saving lives; the research can be allowed (Peter, 2006). Thinkers in Islam 
follow a similar approach and they give the reason that the soul is “breathed” into an embryo when it reaches the 
40th day, thereby making it sacred. The personhood, thus, is acquired after this period when voluntary movements 
would appear (Aksoy, 2005). Buddhism and the less conservative Protestant Churches also state that stem cell 
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research before the 14th day of conception can be allowed.  
 
The cloning controversy has begun to exist after the birth of Dolly the sheep in 1997 which was produced wholly by 
the techniques in cloning (Peter, 2006). Although these techniques have been used in animals models, human 
embryos can be cloned too via “somatic cell nuclear transfer” (SCNT). With this, eggs can be taken from a woman 
and then the nucleus of it can be extracted. What is left behind is the cytoplasm (Maienschein, Sunderland, Rachel, 
Ankeny & Robert, 2008). A nucleus is then obtained from the body cell of a person and then inserted into this 
cytoplasm. In end, the resulting embryo will have the same genetic material with the donor of the nucleus. The 
reason why cloning is important comes from the main target of the stem cell research itself. Since the current aim is 
to allow for the replacement of damaged tissues or organs with the organs grown from stem cells, precautions must 
be taken to minimize the rejection of this transplantation by the patient’s immune system (Curzer, 2004). Cloning 
aids in preventing this from happening since the stem cells that will be used in the therapeutic medical treatment will 
share the same characteristics with the DNA of the patient.  When a new patient walks in to the clinic, however, all 
the pre-existing cells from the previous patient would then need to be destroyed.  
 
Nevertheless, reproductive cloning faced high amounts of criticisms from an ethical perspective and was seen as a 
threat to human “individuality, identity and dignity”. Scientists have been seen as trying to play “God” by acting 
contrary to nature via playing with our genomes. Some scientists state that in pursuit of medical benefits, we risk the 
value of human life to an extent that the risks outweigh the benefits (Ramalho-Santos, Willenbring, 2007). 
 
Further to this, the UN has adopted a resolution in 2005 to prevent all kinds of human cloning with the reasoning 
that they are “incompatible with human dignity and the protection of human life” (UN Human Cloning, 2005). This 
resolution, however, has not been accepted by many (35 states) since it was silent to make a differentiation in 
between reproductive cloning and non-reproductive cloning. Although as Bowring puts out that the distinction in 
between is hard to maintain and be difficult to keep an eye on, (Bowring, 2004), a short explanation of this be that: 
in reproductive cloning, the main aim is to produce a cloned embryo and then implant it into the womb to produce a 
pregnancy and later a cloned child but in non-reproductive cloning, the clone is constructed solely for research 
purposes and is destroyed at an early stage (Maienschein, Sunderland, Rachel, Ankeny & Robert, 2008). In the latter 
version, some countries have even made it legal (New Zealand, Korea), and some have permitted it to be done under 
a licence (UK, China, etc). From religious perspective, similar to what is mentioned above; the conservative 
Christians have not moved away from their strong positions towards stem cell research and have prohibited all kinds 
of cloning. Other beliefs have stood more in line towards the non-reproductive cloning and have not gone against 
the use of cloned stem cells for both research and also for medical aid purposes (Sullivan, 2004). 
 
Since the stem cell research has enormous reliance on the donation of fertile eggs from women, concerns exist as to 
whether potential donors might be subject to both economic and emotional pressures and that exploitation might 
occur. This would not be of surprise considering the fact that the “infertility industry” in the US alone was $6.5 
billion for-profit business even in the year of 2007. Many young women choose the path in becoming donors after 
seeing the ads in online platforms, college newspapers or the social media and the offer can start from the tempting 
amount of $5,000 to $100,000 per extraction. If the increase in research cells is not regulated properly, there would 
be an enormous increase of women donors with low incomes who is not fully aware of this concept nor the health 
risks that it can bring. For instance, there exists no requirement to check up on the donor after the operation and that 
they are simply forgotten after they donate their eggs (Schneider, 2008). Other risks of this can be for the donor to 
loss her fertility or have ovarian torsion, blood clots, kidney disease, premature menopause, ovarian cysts, chronic 
pelvic pain, stroke, reproductive cancers, and in some cases, death (Giudice, 2007). Due to this many countries do 
not permit payment exceeding the medical expenses to prevent the concerns highlighted above from happening. 
However, more protection is required in clinics that do stem cell research and these protections should be governed 
by law. Thus, the main ethical concern here seems to suggest the need for a legal protection. In line with this, the 
more liberal views existing i.e. in China, the UK, USA, Belgium, Korea, and Israel is likely to lead the advancement 
of the law implementation (Giudice, 2007). Hence, the probable exploitation of stem cell research would be legally 
managed in the future. 
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3. Conclusion 
In conclusion, stem cells carry the potential to bring era opening developments to the medical field. Although 
scientist can provide the cure for many diseases which exist in today’s world, diseases such as Parkinson’s disease, 
Alzheimer’s, heart or muscle related injuries still remain to be a problem in which the regenerative medicine cannot 
provide the sufficient aid to. In line with this, they also remain as being subject to a number of ethical and religious 
concerns since this area has not yet settled properly with adequate laws or regulations. Once that happens, as 
highlighted above, most of these concerns would eventually mitigate.  
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